Navigation Links
Young Physicians Demanding Advanced Laparoscopic Energy Instruments
Date:12/11/2007

According to Millennium Research Group's Marketrack(TM) service, the laparoscopic advanced energy market was worth over $100 million in Q3 2007

WALTHAM, Mass., Dec. 11 /PRNewswire/ -- Millennium Research Group's US Laparoscopic Marketrack(TM) results show that in Q3 of 2007, the advanced energy market, which includes open and laparoscopic devices, generated over $100 million in revenue. Due to the demand for advanced energy instruments from young physicians, these products are being used for more applications and in more procedure types than ever before. The shift towards more expensive products has also boosted the market.

Advanced energy surgical instruments consist of ultrasonic and bipolar vessel sealing devices. Ethicon owned 69% revenue share for laparoscopic advanced energy devices in Q3, and over 57% revenue share in Q3 for open advanced energy devices. These devices are used for cutting and coagulating tissue and sealing vessels and offer safer, more precise, simultaneous cutting and coagulation than previous modalities. Many younger physicians have used advanced energy surgical instruments in their training and therefore are familiar with the technology and recognize its advantages, driving devices revenues.

"Average selling prices in the advanced energy category are on the rise," says Jaya Classen, Senior Analyst at Millennium Research Group. "This is due to the adoption of higher-priced products such as the Gyrus-ACMI 3105PK angled shears and the Ligasure V 1500."

MRG offers a number of products covering the global laparoscopic market. For ongoing quarterly tracking of market shares by brand, MRG offers its Laparoscopic Marketrack(TM) service. This service tracks laparoscopic markets, including bladed, bladeless, blunt and hand-assist trocars, advanced energy probes, endolinear cutters and staplers, and reprocessed devices, in the US on a quarterly basis. Besides market share, this service also provides brand- level usage (units, average selling price, and revenue), detailed procedure numbers, and practitioner practice information.

For in-depth analysis and 5-year growth forecasts, MRG offers its Global Markets for Laparoscopic Devices 2008 report series, which includes individual reports on the US and Europe. Companies covered by this market research include Ethicon Endo-Surgery, Covidien (formerly Tyco Healthcare), Gyrus-ACMI, Applied Medical, Olympus, and more.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be

trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
2. Youngs experiment in a hydrogen molecule
3. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
6. Advanced Cell Technology Announces Proposed Financing
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
9. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
10. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
11. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):